Shamburg News · 8-K filed Nov 10, 2026, 8:54 AM EST

Veradermics Reports Third Quarter 2026 Financial Results

MANE · Veradermics, Inc

  • Earnings
  • Materiality: high

Veradermics, Incorporated reported financial results for the quarter ended September 30, 2026, in a press release furnished as Exhibit 99.1. The company reported a net loss of $21.0 million for the third quarter of 2026, compared with a net loss of $20.1 million for the third quarter of 2025. Research and development expenses were $16.1 million and general and administrative expenses were $12.7 million, and cash, cash equivalents, and marketable securities totaled $798.4 million as of September 30, 2026.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 2.02, 9.01, accession 0001827635-26-000041.

Written from the filing by Shamburg Markets. Figures are as reported by the company.